BPCL.NS Bharat Petroleum Corporation Limited
INR·Price 306.60·Mkt cap 1.31TComputed from the latest reported financials and the current market price.
Who's the real player?
A genuine play on this theme — most of its business sits right here.
Is the business healthy?
Healthy business: it turns profit into real cash and earns solid returns on capital.
- High cash flow quality
- Strong FCF conversion
- Conservative accounting (negative accrual ratio)
- Healthy interest coverage
Are the smart people buying?
No ownership-change data for this stock. Conviction is judged from capex and buyback signals alone.
- Strong promoter/insider stake
- High institutional holding
- Significant capex growth
What is management saying?
No earnings-call transcript or filings found for this stock.
Is the price right?
Intrinsic value 1483.17 vs price 306.60 — screens cheap on a cash-flow DCF (383.7% to intrinsic). The base FCF growth assumption of 15% seems optimistic compared to the negative implied growth, making it less believable.
| Intrinsic / share | 1483.17 |
| Price | 306.60 |
| Upside to intrinsic | 383.7% |
| Reverse-DCF implied g | -3.2% |
Base FCF 220.90B · growth 15.0% · discount 12.0% · terminal 5.0%.
Sensitivity — intrinsic value / share
Each cell is the intrinsic value at that growth (across →) and discount rate (down ↓). Center ★ is the base case. Cells green = above price (cheap), red = below (expensive).
| Growth rate → | |||||
|---|---|---|---|---|---|
| Disc ↓ ╲ g | 11% | 13% | 15% | 17% | 19% |
| 10% | 1605.51 | 1895.58 | 2232.41 | 2622.81 | 3074.41 |
| 11% | 1295.15 | 1526.15 | 1793.87 | 2103.6 | 2461.3 |
| 12% | 1074.65 | 1264.07 | ★ 1483.17 | 1736.19 | 2027.92 |
| 13% | 910.24 | 1068.96 | 1252.19 | 1463.41 | 1706.55 |
| 14% | 783.14 | 918.39 | 1074.22 | 1253.53 | 1459.59 |
Through the masters' eyes
Each investor's numeric rules, checked against this stock's metrics: exact math, no guesswork. Tap one to see which rules pass, fail, and what to judge yourself.
Financial statements (INR)
↗ sourceCash-flow lines highlighted — we trust cash over reported profit.
| Line | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 4.55T | 4.40T | 4.47T | 4.66T | — |
| Operating income | 333.46B | 181.45B | 376.74B | 74.23B | — |
| EBITDA | 456.01B | 290.30B | 470.66B | 131.20B | — |
| Net income | 258.43B | 133.37B | 268.59B | 21.31B | — |
| Operating cash flow | 507.69B | 236.78B | 359.70B | 124.66B | — |
| Capex | -194.25B | -151.43B | -95.79B | -85.49B | — |
| Free cash flow | 313.44B | 85.35B | 263.90B | 39.17B | — |
| Total assets | 2.49T | 2.18T | 2.02T | 1.88T | — |
| Total equity | 1.00T | 813.84B | 756.35B | 535.22B | — |
| Total debt | 544.24B | 611.01B | 545.99B | 693.76B | — |
| Cash & equivalents | 3.20B | 5.58B | 23.01B | 23.13B | — |